Tenaya CMO's Stock Sale Occurs Amid Clinical Progress and Analyst Upgrades
Chief Medical Officer Tingley Whittemore sold a block of Tenaya Therapeutics common stock on May 18, 2026. This transaction occurred while the biotech firm's share price was declining significantly over the preceding week. Despite this minor insider activity, the company reported promising interim results from its RIDGE-1 clinical trial and shared …